Quantification of molecular interactions between ApoE, amyloid-beta (Aβ) and laminin: Relevance to accumulation of Aβ in Alzheimer's disease

被引:27
|
作者
Zekonyte, Jurgita [1 ]
Sakai, Kenji [2 ]
Nicoll, James A. R. [3 ]
Weller, Roy O. [3 ]
Carare, Roxana O. [3 ]
机构
[1] Univ Southampton, Fac Engn & Environm, Southampton SO9 5NH, Hants, England
[2] Kanazawa Univ Hosp, Dept Neurol, Kanazawa, Ishikawa, Japan
[3] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2016年 / 1862卷 / 05期
基金
英国工程与自然科学研究理事会; 英国生物技术与生命科学研究理事会;
关键词
Apolipoprotein E; Perivascular clearance pathways; Laminin; Atomic force microscopy; Amyloid-beta; Cerebral amyloid angiopathy; Alzheimer's disease; ISOFORM-SPECIFIC BINDING; APOLIPOPROTEIN-E; FORCE SPECTROSCOPY; ANGIOPATHY; PROTEIN; BRAIN; ATTACHMENT; CLEARANCE; DRAINAGE; REMOVAL;
D O I
10.1016/j.bbadis.2015.08.025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Accumulation of amyloid-beta (A beta) in plaques in the brain and in artery walls as cerebral amyloid angiopathy indicates a failure of elimination of A beta from the brain with age and Alzheimer's disease. A major pathway for elimination of A beta and other soluble metabolites from the brain is along basement membranes within the walls of cerebral arteries that represent the lymphatic drainage pathways for the brain. The motive force for the elimination of A beta along this perivascular pathway appears to be the contrary (reflection) wave that follows the arterial pulse wave. Following injection into brain parenchyma, A beta rapidly drains out of the brain along basement membranes in the walls of cerebral arteries; such drainage is impaired in apolipoprotein E epsilon 4 (ApoE4) mice. For drainage of A beta to occur in a direction contrary to the pulse wave, some form of attachment to basement membrane would be required to prevent reflux of A beta back into the brain during the passage of the subsequent pulse wave. In this study, we show first that apolipoprotein E co-localizes with A beta in basement membrane drainage pathways in the walls of arteries. Secondly, we show by Atomic Force Microscopy that attachment of ApoE4/A beta complexes to basement membrane laminin is significantly weaker than ApoE3/A beta complexes. These results suggest that perivascular elimination of ApoE4/A beta complexes would be less efficient than with other isoforms of apolipoprotein E, thus endowing a higher risk for Alzheimer's disease. Therapeutic correction for ApoE4/A beta/laminin interactions may increase the efficiency of elimination of A beta in the prevention of Alzheimer's disease. This article is part of a Special Issue entitled: Vascular Contributions to Cognitive Impairment and Dementia edited by M. Paul Murphy, Roderick A. Corriveau and Donna M. Wilcock. (c) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:1047 / 1053
页数:7
相关论文
共 50 条
  • [31] Role of apoE/Aβ interactions in the pathogenesis of Alzheimer’s disease and cerebral amyloid angiopathy
    David M. Holtzman
    Journal of Molecular Neuroscience, 2001, 17 : 147 - 155
  • [32] The Alzheimer's Disease Amyloid-Beta Hypothesis in Cardiovascular Aging and Disease JACC Focus Seminar
    Stakos, Dimitrios A.
    Stamatelopoulos, Kimon
    Bampatsias, Dimitrios
    Sachse, Marco
    Zormpas, Eleftherios
    Vlachogiannis, Nikolaos I.
    Tual-Chalot, Simon
    Stellos, Konstantinos
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (08) : 952 - 967
  • [33] Fragmentation of brain apolipoprotein E (ApoE) and its relevance in Alzheimer's disease
    Amponsah, Asiamah Ernest
    Feng, Baofeng
    Guo, Ruiyun
    Zhang, Wei
    He, Jingjing
    Kong, Desheng
    Dong, Tianyu
    Ma, Jun
    Cui, Huixian
    REVIEWS IN THE NEUROSCIENCES, 2020, 31 (06) : 589 - 603
  • [34] Alzheimer's disease amyloid-beta peptide modulates apolipoprotein E isoform specific receptor binding
    Hone, E
    Martins, IJ
    Jeoung, M
    Ji, TH
    Gandy, SE
    Martins, RN
    JOURNAL OF ALZHEIMERS DISEASE, 2005, 7 (04) : 303 - 314
  • [35] Plasma Amyloid-Beta Levels in Korean Patients with Alzheimer's Disease
    Cho, Sun Young
    Kang, So Young
    Lee, Woo In
    CLINICAL LABORATORY, 2016, 62 (08) : 1591 - 1593
  • [36] Amyloid-beta and tau proteins as biochemical markers of Alzheimer's disease
    Sobów, T
    Flirski, M
    Liberski, PP
    ACTA NEUROBIOLOGIAE EXPERIMENTALIS, 2004, 64 (01) : 53 - 70
  • [37] Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer’s disease
    Yang Xiang
    Xian-Le Bu
    Yu-Hui Liu
    Chi Zhu
    Lin-Lin Shen
    Shu-Sheng Jiao
    Xiao-Yan Zhu
    Brian Giunta
    Jun Tan
    Wei-Hong Song
    Hua-Dong Zhou
    Xin-Fu Zhou
    Yan-Jiang Wang
    Acta Neuropathologica, 2015, 130 : 487 - 499
  • [38] Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
    Maria Luisa Moro
    Andrew Stephen Phillips
    Katie Gaimster
    Christian Paul
    Amritpal Mudher
    James A. R. Nicoll
    Delphine Boche
    Acta Neuropathologica Communications, 6
  • [39] Lipid peroxidation and Alzheimer's disease: Key role of Amyloid-beta
    Kontush, Anatol
    OCL-OILSEEDS AND FATS CROPS AND LIPIDS, 2006, 13 (01) : 46 - 53
  • [40] Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer's Disease
    Baranello, Robert J.
    Bharani, Krishna L.
    Padmaraju, Vasudevaraju
    Chopra, Nipun
    Lahiri, Debomoy K.
    Greig, Nigel H.
    Pappolla, Miguel A.
    Sambamurti, Kumar
    CURRENT ALZHEIMER RESEARCH, 2015, 12 (01) : 32 - 46